Comparison of Multiparametric MRI, [<sup>68</sup>Ga]Ga-PSMA-11 PET-CT, and Clinical Nomograms for Primary T and N Staging of Intermediate-to-High-Risk Prostate Cancer
Purpose of the Report: Although multiparametric magnetic resonance imaging (mpMRI) is commonly used for the primary staging of prostate cancer, it may miss non-enlarged metastatic lymph nodes. Positron emission tomography-computed tomography targeting the prostate-specific membrane antigen (PSMA PET...
Main Authors: | Omar Marek Tayara, Kacper Pełka, Jolanta Kunikowska, Wojciech Malewski, Katarzyna Sklinda, Hubert Kamecki, Sławomir Poletajew, Piotr Kryst, Łukasz Nyk |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/24/5838 |
Similar Items
-
Intra-Individual Comparison of Physiologic [<sup>68</sup>Ga]Ga-PSMA-11 and [<sup>18</sup>F]PSMA-1007 Uptake in Ganglia in Patients with Prostate Cancer: A Retrospective, Monocentric Analysis
by: Emil Novruzov, et al.
Published: (2023-05-01) -
Imaging GRPr Expression in Metastatic Castration-Resistant Prostate Cancer with [<sup>68</sup>Ga]Ga-RM2—A Head-to-Head Pilot Comparison with [<sup>68</sup>Ga]Ga-PSMA-11
by: René Fernández, et al.
Published: (2023-12-01) -
Analysis of Pros and Cons in Using [<sup>68</sup>Ga]Ga-PSMA-11 and [<sup>18</sup>F]PSMA-1007: Production, Costs, and PET/CT Applications in Patients with Prostate Cancer
by: Costantina Maisto, et al.
Published: (2022-06-01) -
[<sup>68</sup>Ga]Ga-PSMA-11: The First FDA-Approved <sup>68</sup>Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
by: Ute Hennrich, et al.
Published: (2021-07-01) -
Optimization of Automated Radiosynthesis of Gallium-68-Labeled PSMA11 with Two [<sup>68</sup>Ge]Ge/[<sup>68</sup>Ga]Ga Generators: Fractional Elution or Prepurification?
by: Flore Durieux, et al.
Published: (2023-11-01)